Showing results (11-20 of 728) with videos related to
Sort By:
Pageof 73
Cardiovascular & Hematological Agents in Medicinal Chemistry|August 12, 2009
Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitorsCostantino Smaldone, Salvatore Brugaletta, Vincenzo Pazzano, et al.Vascular Pharmacology|September 22, 2023
Hypertension, coronary artery disease and myocardial ischemic syndromesMassimo Volpe, Giovanna GalloEuropean Cardiology|May 19, 2020
Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?Allegra Battistoni, Massimo VolpeCurrent Medical Research and Opinion|July 22, 2004
Treatment priorities and current prescribing patterns in hypertension: results of GRASP, an international physician surveyMassimo Volpe, Elizabeth MachadoAdvances in Therapy|December 29, 2018
Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of OlmesartanStefano Omboni, Massimo VolpeGiornale Italiano Di Cardiologia (2006)|September 9, 2008
[Residual risk in cardiovascular prevention]Claudio Rapezzi, Massimo VolpeJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 10, 2009
2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk conceptMassimo Volpe, Giuliano TocciEuropean Heart Journal. Cardiovascular Pharmacotherapy|April 15, 2020
Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?Allegra Battistoni, Massimo VolpeEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
The enigma of resistant hypertension: from lifestyle changes and pharmacological treatment to renal denervationMassimo Volpe, Giovanna GalloVascular Health and Risk Management|June 30, 2012
Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diureticMassimo Volpe, Giuliano TocciPageof 73